HLA-Typed Peripheral Blood Mononuclear Cells

Human Leukocyte Antigen (HLA) information is a critical factor for donor/recipient matching for organ and bone marrow transplants. HLA-typed peripheral blood mononuclear cells (PBMCs) are used for researching cell therapies, cancer vaccine development and patient stratification for immune-oncology drug discovery.

Our HLA-typed PBMCs are collected at FDA-licensed donor centers and further processed using Ficoll gradient and several washes to remove platelets.

All donors are tested for HIV, Hepatitis B and C, WNV, CMV, and other blood-borne pathogens.

All biospecimens are obtained from properly consented donors. We conform to HIPAA standards to protect the privacy of the donor’s personal health information.

Human Material Precaution 
It is best to use caution when handling any human cells. We recommend all human cells should be handled as if potentially infectious following biosafety level 2 procedures.

Even with infectious virus assays or viral antigen assays, a negative test result may leave open the possible existence of latent viruses.